Clinical study of flunarizine for preventing the recurrence of cerebral infarction in 298 patients

SHI Hong,SUN Xiaojiang,LU Lei,SHEN Jie,XUE Bo
DOI: https://doi.org/10.7619/jcmp.201301026
2013-01-01
Abstract:Objective To explore the clinical effect of the added flunarizine for preventing the recurrence of cerebral infarction.Methods A total of 298 patients with cerebral infarction were divided into 2 groups randomly,and were given the same basic treatment.Aspirin and flunarizine were then added in observation group(n=50) while single aspirin added in control group.Six months after treatment,the total therapeutic effects,hemorheology indexes,adverse reactions and reoccurrence rate within 1 year of two groups were compared.Results After 6-month treatment,the marked efficacy in the observation group was obviously higher than that in the control group.The reoccurrence rate of cerebral infarction within 1 year in the observation group was obviously lower than that in the control group.After treatment,various hemorheology indexes obviously improved in both groups,while the improving condition in the observation group was superior to that in the control group.With 1-year follow-up,the incidence rate of adverse reactions was 11.3%,and the reactions gradually disappeared after continuous administration.Conclusion The added flunarizine can conspicuously prevent the reoccurrence of cerebral infarction with slight adverse reactions.It’s worthy of popularization.
What problem does this paper attempt to address?